Cargando…
When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies
T cells engineered with chimeric antigen receptors (CAR) have demonstrated its widespread efficacy as a targeted immunotherapeutic modality. Yet, concerns on its specificity, efficacy and generalization prevented it from being established into a first-line approach against cancers. By reviewing chal...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905244/ https://www.ncbi.nlm.nih.gov/pubmed/35280746 http://dx.doi.org/10.3389/fonc.2022.837995 |